HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Standardization of allergen-specific immunotherapy vaccines.

AbstractIn the 1970s and 1980s, scientific methods were introduced in the standardization of allergen vaccines and, in combination with improved documentation of the clinical benefits obtained using standardized vaccines, specific allergy treatment as a scientifically based, reproducible, and safe treatment for allergic disease was established. This article describes important issues in the control of source materials and vaccine preparation as part of the European standardization of allergen vaccines, and also includes a discussion of vaccines that are based on recombinant allergens, which may appear on the market in the near future.
AuthorsMichael D Spangfort, Jørgen Nedergaard Larsen (Affiliation: ALK-Abelló, Bøge Allé 6-8, DK - 2970 Hørsholm, Denmark. msp at dk.alk-abello.com)
JournalImmunology and allergy clinics of North America (Immunol Allergy Clin North Am) Vol. 26 Issue 2 Pg. 191-206, v-vi (May 2006) ISSN: 0889-8561 [Print] United States
PMID16701140 (Publication Type: Journal Article, Review)
Chemical References
  • Allergens
  • Vaccines
Topics
  • Allergens (immunology)
  • Desensitization, Immunologic (methods, standards)
  • Europe
  • Humans
  • Hypersensitivity (immunology, therapy)
  • Vaccines (standards)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD